Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Sorafenib News Monitoring

Get by Email • RSS

Published on Apr 14, 2025

FDA Approves Opdivo® Plus Yervoy® for Unresectable or Metastatic Hepatocellular Carcinoma

Bristol Myers Squibb (announced that the FDA approved Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a first-line treatment for adult patients with unresectable or metastatic hepatocellular carcinoma (HCC), the most common primary liver cancer. This …

Source: American Pharmaceutical Review - Neutral
Published on Apr 14, 2025

BMS gets another FDA okay for Opdivo/Yervoy combo

Bristol-Myers Squibb has claimed its second FDA approval in the space of a few days for its immuno-oncology combination of Opdivo and Yervoy, this time in newly diagnosed liver cancer. PD-1 inhibitor Opdivo (nivolumab) and CTLA4 inhibitor Yervoy ( …

Source: pharmaphorum - Neutral
Published on Apr 14, 2025

BMS receives FDA approval for immunotherapy combination in liver cancer

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been approved by the US Food and Drug Administration (FDA) to treat patients with hepatocellular carcinoma (HCC), the most common type of liver cancer. Opdivo (nivolumab) …

Source: PMLiVE - Neutral
Published on Apr 14, 2025

FDA OKs First-line Nivolumab + Ipilimumab in Advanced HCC

The US Food and Drug Administration (FDA) has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, Bristol Myers Squibb) as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC). The …

Source: Medscape - Neutral
Published on Apr 13, 2025

BMS Immunotherapy Combo Gets Two FDA Nods for GI Cancers in Span of a Week

The pairing of two Bristol Myers Squibb immunotherapies is now permitted for the first-line treatment of two types of gastrointestinal cancers, after regulatory decisions handed out this past week that convert the accelerated approval status of the drug …

Source: MedCity News - Neutral
Published on Apr 11, 2025

FDA Approves Nivolumab/Ipilimumab in First-Line Hepatocellular Cancer

The FDA approved the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). This regulatory decision is supported by findings from the phase 3 CheckMate 9DW trial …

Source: Targeted Oncology - Pending
Published on Apr 11, 2025

FDA OKs Nivolumab/Ipilimumab in Unresectable/Metastatic HCC

The FDA has approved nivolumab (Opdivo) plus ipilimumab (Yervoy) for patients with unresectable or metastatic hepatocellular carcinoma, according to a press release from the agency.1 The approval was based on results from the phase 3 CheckMate 9DW trial ( …

Source: Cancer Network - New Jersey - Pending
Published on Apr 11, 2025

FDA Approves Opdivo Plus Yervoy for Advanced HCC

The Food and Drug Administration (FDA) has approved the combination use of Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic hepatocellular carcinoma (HCC), the agency has announced. …

Source: Cure Today - Neutral
Published on Apr 11, 2025

FDA approves nivolumab with ipilimumab for unresectable or metastatic hepatocellular carcinoma

On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with ipilimumab (Yervoy, Bristol Myers Squibb Company) for the first-line treatment of adult patients with unresectable or metastatic …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on Apr 11, 2025

Nivolumab With Ipilimumab Approved by FDA for Use in Hepatocellular Carcinoma

The FDA approved the combination of nivolumab (Opdivo; Bristol Myers Squibb Company) with ipilimumab (Yervoy; Bristol Myers Squibb Company) on April 11 to provide a new method of treatment for hepatocellular carcinoma (HCC), specifically in its …

Source: The American Journal of Managed Care - Neutral
Published on Apr 11, 2025

Dr He on the FDA Approval of Nivolumab Plus Ipilimumab for Unresectable/Metastatic HCC

“The median OS [with nivolumab plus ipilimumab] was 23.7 months—the longest so far for advanced HCC. I found that to be very exciting [as it] sort of creates a new landmark for this disease.” Aiwu Ruth He, MD, PhD, a gastrointestinal medical oncologist at …

Source: OncLive - Pending
Published on Apr 11, 2025

FDA Approves Nivolumab With Ipilimumab for First-Line Treatment of Adult Patients With HCC

The FDA approved nivolumab (Opdivo, Bristol Myers Squibb Company) with ipilimumab (Yervoy, Bristol Myers Squibb Company) for adult patients with unresectable or metastatic hepatocellular carcinoma (HCC) in the first-line setting. This approval is supported …

Source: Pharmacy Times - Neutral
Published on Apr 11, 2025

FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC

The FDA announced its approval of frontline nivolumab (Opdivo) plus ipilimumab (Yervoy) for use in adult patients with unresectable or metastatic hepatocellular carcinoma (HCC), according to an announcement from the agency.1 The approval is based on data …

Source: Oncology Nursing News - Pending
Published on Apr 11, 2025

FDA Approves Nivolumab Plus Ipilimumab for Unresectable or Metastatic Hepatocellular Carcinoma

The FDA has approved nivolumab (Opdivo) in combination with ipilimumab (Yervoy) for the first-line treatment of adult patients with unresectable or metastatic hepatocellular carcinoma (HCC).1 This regulatory decision was supported by findings from the …

Source: OncLive - Pending
Published on Apr 12, 2025

Combination Therapy of Transarterial Chemoembolization, Lenvatinib, and PD-1 Inhibitors Achieves Significant Tumor ...

Introduction Hepatocellular carcinoma (HCC) is one of the most common malignancies and the leading cause of cancer-related deaths globally, with approximate 45% of new HCC cases worldwide originating from China.1,2 With advancing insights into the …

Source: Dove Medical Press - Neutral
Published on Jan 2, 2025

Regulatory tracker: Europe serves up earlier lymphoma nod for Roche's Columvi as final review of Eisai's Leqembi kicks ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Be sure to come back regularly for …

Source: Fierce Pharma - Neutral
Published on Apr 14, 2025

BMS’ Opdivo combo approved in US for hepatocellular carcinoma

The US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in combination with Yervoy (ipilimumab) as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC), …

Source: Pharmaceutical Technology - Pending
Published on Apr 14, 2025

Single-Cell Transcriptional Analysis Reveals the Mechanism of AZD6738 in HCC Immunotherapy via EZH2 Targeting

Introduction Hepatocellular carcinoma (HCC) stands as the fifth most prevalent malignancy globally and ranks as the second principal contributor to cancer-related mortality.1,2 HCC is one of several subtypes of primary liver cancer (PLC), which also …

Source: Dove Medical Press - Neutral
Published on Apr 12, 2025

Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit

Introduction Liver cancer is one of the most prevalent cancers worldwide, ranking as the sixth most commonly diagnosed cancer globally with approximately 865,000 new cases and the third leading cause of cancer-related deaths with around 758,000 fatalities. …

Source: Dove Medical Press - Neutral

06 days 19:03:03

Featured Releases

Got News to Share? · Submit · See All

Published on April 15, 2025 - 05:00 GMT

Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on April 15, 2025 - 05:00 GMT

Communiqué de presse : Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de ...

Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de nouvelles données sur l’asthme et prévoit de nouvelles études cliniques sur la BPCO De nouvelles données de phase II démontrent l’efficacité de l’amlitélimab dans le …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on April 14, 2025 - 15:00 GMT

Atticus Pharma Announces Initiation of the First Human Clinical Trial of ATC-002

ATC-002 is an Investigational Pharmaceutical Product Candidate for Androgenic Alopecia GREENVILLE, SC, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- • ATC-002 is a twice-daily treatment designed to stimulate new hair growth in people …

Distribution channels: Business & Economy, Companies ...
Published on April 14, 2025 - 10:28 GMT

Cancer Profiling Market to Reach USD 15.0 Billion by 2035, Growing at 7.11% CAGR | Abbott Laboratories

US, NY, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- The cancer profiling market is experiencing significant growth, driven by the rising prevalence of cancer and the increasing demand for personalized medicine. Cancer profiling involves …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 14, 2025 - 12:00 GMT

Zeal Specialty Pharmacy Announces Expansion to Second Location

PITTSBURGH, PA, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Zeal Specialty Pharmacy, a nationally licensed rare disease specialty pharmacy, proudly announces the opening of a second operational location, based in Peachtree Corners, Georgia. The …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 00:07 GMT

Zymra Under Review: Natural Fat Burning System - Safe OTC Alternative to GLP-1 Drugs

New York City, April 14, 2025 (GLOBE NEWSWIRE) -- 1. Introduction Losing weight is more complicated than simply eating less and moving more. For many adults, especially those over the age of 30, persistent weight gain is the result of biological resistance …

Distribution channels: Consumer Goods, Media, Advertising & PR ...
Published on April 14, 2025 - 17:03 GMT

Attorney General Bonta Calls on Congressional Leaders to Pass Law Prohibiting PBMs from Owning or Operating Pharmacies

Bipartisan coalition of attorneys general writes that federal action is needed to protect consumers and small businesses OAKLAND — California Attorney General Rob Bonta today joined a bipartisan coalition of 39 attorneys general in urging the leaders of …

Distribution channels:
Published on April 14, 2025 - 16:37 GMT

April 14, 2025 - Attorney General Miyares Joins Bipartisan Coalition Asking Congress to Prohibit PBMs from Owning or ...

Commonwealth of Virginia Office of the Attorney General Jason S. Miyares Attorney General 202 North 9th Street Richmond, Virginia 23219 804-786-2071 FAX 804-786-1991 Virginia Relay Service 800-828-1120 For media inquiries only, contact: Shaun Kenney …

Distribution channels:

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 803,375,306 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on April 15, 2025 - 08:53 GMT

Bandage Contact Lenses Market Expected to Hit USD 5.0 Billion by 2035 with a Remarkable 6.98% CAGR

Hospitals & Eye Care Clinics: Dominating due to clinical prescriptions and post-op care US, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Global Bandage Contact Lenses Market Set to Reach USD 5 Billion by 2035, Driven by …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 08:01 GMT

Dr. Sam Speron Introduces LS-083 One Shot Cool Ionic Hair Curler for At-Home Professional Styling

Dr. Sam Speron Introduces LS-083 One Shot Cool Ionic Hair Curler for At-Home Professional Styling CHICAGO, IL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Dr. Sam Speron, a board-certified plastic surgeon and founder of Dr. Speron' …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on April 15, 2025 - 07:45 GMT

BoxLogix Transforms Dot Foods’ Cold Order Fulfillment with Advanced Packing Automation

Scalable automation boosts packing speed, accuracy, and efficiency in Dot Foods’ cold chain operations. PRAIRIE DU CHIEN, WI, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- BoxLogix Transforms Dot Foods’ Cold Order Fulfillment with Advanced …

Distribution channels: Automotive Industry, Food & Beverage Industry ...
Published on April 15, 2025 - 06:21 GMT

Creative Biogene Supercharges Gene Editing Capabilities with Comprehensive Microbe Genome Editing Service

NEW YORK, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Creative Biogene, a cell and gene biotechnology company focused on advancing transformative cell and gene therapies, today announced that it has launched genome editing technology …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 05:15 GMT

U.S. News & World Report Names St. James Place Among Best Senior Living Communities for 2025

St. James Place is the only Independent Living facility in Louisiana to be recognized by U.S. News & World Report as a 2025 Best Senior Living community. BATON ROUGE, LA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- St. James Place …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 05:11 GMT

Earth Buddy Expands Access to Holistic Pet Care with Launch of New Website

Earth Buddy, a trusted leader in pet wellness, proudly announces the launch of its new website. LONGMONT, CO, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Earth Buddy, a trusted leader in pet wellness, proudly announces the launch of its …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on April 15, 2025 - 04:29 GMT

South Florida Health Tech Startup Joins Microsoft’s Elite Accelerator Program

House Call The App by Scarlet Technologies Inc partners with Microsoft Startup Hub to scale its revolutionary home health tech solution nationwide. WEST PALM BEACH , FL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- House Call The App by …

Distribution channels: Beauty & Hair Care, Healthcare & Pharmaceuticals Industry ...
Published on April 14, 2025 - 22:56 GMT

'Do No Harm': Advancing Debridement Documentation with Proven Clinical Efficacy & Medical Necessity with SnapshotNIR

SnapshotNIR supports a patient-centered approach by ensuring that every clinical decision is based on accurate, evidence-driven data. CALGARY, ALBERTA, CANADA, April 14, 2025 /⁨EINPresswire.com⁩/ -- As a leader in advanced medical technology, Kent …

Distribution channels: Business & Economy, Companies ...
Published on April 14, 2025 - 21:15 GMT

Scyne join forces with 6clicks to transform risk and compliance for Government agencies and regulators

6clicks and Scyne are delivering AI-powered GRC tailored for government—enhancing oversight, streamlining compliance, and supporting regulatory resilience. MELBOURNE, AUSTRALIA, April 15, 2025 /⁨EINPresswire.com⁩/ -- 6clicks is proud to announce a …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on April 14, 2025 - 21:03 GMT

Obatala Sciences and Ainnocence Announce Partnership to Transform Drug Discovery Through AI and Human Biological Models

MOUNTAIN VIEW, CA, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Highlights: • Obatala Sciences and Ainnocence’s groundbreaking partnership addresses the FDA’s recent call for human-relevant methods for new drug development. • The …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on April 14, 2025 - 21:00 GMT

Next Generation Wellness: Red Light Method Brings Cutting Edge Recovery and Fitness to the Masses

Red Light Method emerges as a powerful new player—fusing science-backed recovery with modern fitness modalities to deliver life-enhancing results at scale. RENO, NV, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- As the wellness market …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on April 14, 2025 - 20:45 GMT

Takapuna clinic offers same day implant procedure for tooth loss

TAKAPUNA, NORTH SHORE, AUCKLAND, NEW ZEALAND, April 15, 2025 /⁨EINPresswire.com⁩/ -- Noble Dental Specialists Takapuna, North Shore, now offers a same day implant procedure for patients needing fast and durable tooth replacement. The innovative …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on April 14, 2025 - 20:22 GMT

Elimu Informatics Joins AMIA as a Silver Corporate Partner to Advance Health Informatics Innovation

Elimu partners with AMIA as a Silver Corporate Partner, reinforcing its commitment to smarter data, better care, and health IT collaboration. EL CERRITO, CA, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Elimu Informatics is proud to …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on April 14, 2025 - 20:10 GMT

Gaine Technology Welcomes Jeff Kohrman as SVP to Lead Growth Efforts Within the Payer Market Vertical

SAN LUIS OBISPO, CA, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Jeff Kohrman has joined Gaine Technology as Senior Vice President (SVP) to lead growth efforts within the Payer Market vertical. With more than 20 years of experience in …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 08:00 GMT

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on April 14, 2025 - 19:34 GMT

New Podcast Alert: The TPE Blueprint Launches as the First-Ever Series on Biohacking with Therapeutic Plasma Exchange

Powered by MDLifespan, this breakthrough podcast explores detoxification, longevity, and peak performance through cutting-edge blood filtration science. CHICAGO, IL, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- The TPE Blueprint, the …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on April 14, 2025 - 19:09 GMT

Fresh Start Surgical Gifts Transforms Lives of Children From Around the World Through Surgery Weekend

SAN DIEGO, CA, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- In their ongoing mission of bettering the lives of children around the world, San Diego-based nonprofit Fresh Start Surgical Gifts recently hosted another transformative Surgery …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on April 14, 2025 - 19:08 GMT

Nominate a Nurse in Your Life: Honoring our March Nurse Giveaway Winners

Celebrating nurses who go above and beyond—Snellings Law honors three local healthcare heroes through its North Texas Nurse Giveaway. FRISCO, TX, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Snellings Law is proud to spotlight three …

Distribution channels: Companies, Emergency Services ...
Published on April 15, 2025 - 07:00 GMT

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeutics Cyprumed will be eligible to receive up to $493 million in upfront, development, regulatory and sales milestones INNSBRUCK, Austria, April 15, 2025 …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 07:00 GMT

1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease ...

Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST Biotherapeutics, Inc. (1STBIO), a clinical-stage biopharmaceutical …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...